Advert - Pierre Fabre

For failing to certify representatives’ briefing materials and one presentation aimed at health professionals which promoted an unlicensed medicine, including briefing materials related to Toviaz (fesoterodine) that were misleading, not capable of substantiation, and which advocated a course of action likely to lead to a breach of the Code, Pierre Fabre was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 3.1 - Promoting an unlicensed medicine
Clause 7.2 - Providing misleading information
Clause 7.4 - Making an unsubstantiated claim
Clause 9.1 - Failing to maintain high standards
Clause 14.1 - Failing to certify material
Clause 15.9 - Producing briefing material likely to lead to a breach of the Code

Advert - May 2018